Precision BioSciences's Total Assets for the quarter that ended in Dec. 2023 was $159.78 Mil.
During the past 12 months, Precision BioSciences's average Total Assets Growth Rate was -11.30% per year.
During the past 3 years, the average Total Assets Growth Rate was -10.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 2.20% per year.
During the past 7 years, Precision BioSciences's highest 3-Year average Total Assets Growth Rate was 82.80%. The lowest was -10.60%. And the median was 10.25%.
Precision BioSciences Total Assets Historical Data
The historical data trend for Precision BioSciences's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Precision BioSciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Precision BioSciences (NAS:DTIL) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Precision BioSciences's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Precision BioSciences Total Assets Related Terms
Thank you for viewing the detailed overview of Precision BioSciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Precision BioSciences (Precision BioSciences) Business Description
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DTIL has been successfully added to your 